|
|
|
Conversations at ASCO 2008: The IMF Interviews
|
|
|
|
|
"Basically all the options are on the table. We have to figure out in controlled trials… which is the real option that we can translate into a significant clinical benefit." |
|
|
|
|
"The fact that lenalidomide with low dose dexamethasone as primary therapy was giving us results in the same range as transplant was very surprising and very encouraging at the same time." |
|
|
print
back to top